Targeting Unc-51 Like Autophagy Activating Kinase 1 (ULK1) in Acute Myeloid Leukemia (AML)

AML, autophagy inhibition, combination therapy, ROS, DNA damage

Source: Clinical Lymphoma, Myeloma and Leukemia - October 1, 2017 Category: Hematology Authors: Seemana Bhattacharya, Sujan Piya, Teresa McQueen, Marina Konopleva, Michael Andreeff, Gautam Borthakur Source Type: research